Back

Antiplatelet regimens and beyond in acute coronary syndromes: Role of lipid lowering, P2 Y12 monotherapy and more.

27 August 2022 (09:07 - 09:26)
Organised by:
Congress Presentation Part of: Acute coronary syndromes in complex patients and lesions: what’s new? Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Davide Capodanno

University of Catania, Catania (Italy)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture in “Acute coronary syndromes in complex patients and lesions: what’s new?"
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
Safety and Efficacy of Biodegradable Polymer Biolimus-Eluting Stents in Patients with Non-ST-elevation Acute Coronary Syndrome: A Pooled Analysis of GLASSY and TWILIGHT
Doctor A. Spirito (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Acute coronary syndromes in complex patients and lesions: what’s new?
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 09:07 CET
You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
thumbnail
Webinar
Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
Congress Presentation
Antithrombotic therapy in patients with ACS: default and alternative strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources